nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—decidua—ovarian cancer	0.0568	0.148	CbGeAlD
Vildagliptin—DPP9—female gonad—ovarian cancer	0.0407	0.106	CbGeAlD
Vildagliptin—DPP9—testis—ovarian cancer	0.0361	0.0941	CbGeAlD
Vildagliptin—DPP4—embryo—ovarian cancer	0.0282	0.0736	CbGeAlD
Vildagliptin—DPP9—lymph node—ovarian cancer	0.0261	0.0682	CbGeAlD
Vildagliptin—DPP4—epithelium—ovarian cancer	0.023	0.06	CbGeAlD
Vildagliptin—DPP4—uterine cervix—ovarian cancer	0.0228	0.0595	CbGeAlD
Vildagliptin—DPP4—decidua—ovarian cancer	0.0217	0.0567	CbGeAlD
Vildagliptin—DPP4—endometrium—ovarian cancer	0.0206	0.0538	CbGeAlD
Vildagliptin—DPP4—uterus—ovarian cancer	0.019	0.0496	CbGeAlD
Vildagliptin—DPP4—female reproductive system—ovarian cancer	0.0171	0.0446	CbGeAlD
Vildagliptin—DPP4—bone marrow—ovarian cancer	0.0161	0.0421	CbGeAlD
Vildagliptin—DPP4—female gonad—ovarian cancer	0.0156	0.0406	CbGeAlD
Vildagliptin—DPP4—vagina—ovarian cancer	0.0155	0.0403	CbGeAlD
Vildagliptin—DPP4—testis—ovarian cancer	0.0138	0.036	CbGeAlD
Vildagliptin—Blister—Vinorelbine—ovarian cancer	0.0122	0.0198	CcSEcCtD
Vildagliptin—Fatigue—Altretamine—ovarian cancer	0.01	0.0162	CcSEcCtD
Vildagliptin—DPP4—lymph node—ovarian cancer	0.01	0.0261	CbGeAlD
Vildagliptin—Skin exfoliation—Melphalan—ovarian cancer	0.00963	0.0156	CcSEcCtD
Vildagliptin—Skin exfoliation—Vinorelbine—ovarian cancer	0.00842	0.0136	CcSEcCtD
Vildagliptin—Asthenia—Altretamine—ovarian cancer	0.00834	0.0135	CcSEcCtD
Vildagliptin—Infection—Carboplatin—ovarian cancer	0.00798	0.0129	CcSEcCtD
Vildagliptin—Dermatitis bullous—Topotecan—ovarian cancer	0.00783	0.0127	CcSEcCtD
Vildagliptin—Dizziness—Altretamine—ovarian cancer	0.00768	0.0125	CcSEcCtD
Vildagliptin—Nausea—Altretamine—ovarian cancer	0.0069	0.0112	CcSEcCtD
Vildagliptin—Liver function test abnormal—Melphalan—ovarian cancer	0.00676	0.011	CcSEcCtD
Vildagliptin—Dermatitis bullous—Vinorelbine—ovarian cancer	0.0067	0.0109	CcSEcCtD
Vildagliptin—Gastrooesophageal reflux disease—Paclitaxel—ovarian cancer	0.00656	0.0106	CcSEcCtD
Vildagliptin—Weight increased—Topotecan—ovarian cancer	0.00588	0.00954	CcSEcCtD
Vildagliptin—Infestation NOS—Topotecan—ovarian cancer	0.00576	0.00935	CcSEcCtD
Vildagliptin—Infestation—Topotecan—ovarian cancer	0.00576	0.00935	CcSEcCtD
Vildagliptin—Skin exfoliation—Paclitaxel—ovarian cancer	0.00566	0.00918	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Topotecan—ovarian cancer	0.00545	0.00884	CcSEcCtD
Vildagliptin—Pancreatitis—Vinorelbine—ovarian cancer	0.00542	0.00879	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Melphalan—ovarian cancer	0.00534	0.00865	CcSEcCtD
Vildagliptin—Hepatitis—Melphalan—ovarian cancer	0.00507	0.00821	CcSEcCtD
Vildagliptin—Connective tissue disorder—Melphalan—ovarian cancer	0.00498	0.00807	CcSEcCtD
Vildagliptin—Infestation—Vinorelbine—ovarian cancer	0.00493	0.00799	CcSEcCtD
Vildagliptin—Infestation NOS—Vinorelbine—ovarian cancer	0.00493	0.00799	CcSEcCtD
Vildagliptin—Skin exfoliation—Docetaxel—ovarian cancer	0.0048	0.00778	CcSEcCtD
Vildagliptin—Tremor—Chlorambucil—ovarian cancer	0.00474	0.00769	CcSEcCtD
Vildagliptin—Blister—Epirubicin—ovarian cancer	0.0047	0.00762	CcSEcCtD
Vildagliptin—Angiopathy—Topotecan—ovarian cancer	0.0047	0.00761	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.00466	0.00756	CcSEcCtD
Vildagliptin—Chills—Topotecan—ovarian cancer	0.00464	0.00753	CcSEcCtD
Vildagliptin—Angioedema—Chlorambucil—ovarian cancer	0.00462	0.0075	CcSEcCtD
Vildagliptin—Malnutrition—Topotecan—ovarian cancer	0.0045	0.0073	CcSEcCtD
Vildagliptin—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00441	0.00715	CcSEcCtD
Vildagliptin—Blister—Doxorubicin—ovarian cancer	0.00435	0.00705	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00435	0.00705	CcSEcCtD
Vildagliptin—Angioedema—Topotecan—ovarian cancer	0.00412	0.00667	CcSEcCtD
Vildagliptin—Infection—Chlorambucil—ovarian cancer	0.0041	0.00665	CcSEcCtD
Vildagliptin—Angiopathy—Vinorelbine—ovarian cancer	0.00402	0.00651	CcSEcCtD
Vildagliptin—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00397	0.00644	CcSEcCtD
Vildagliptin—Malnutrition—Vinorelbine—ovarian cancer	0.00385	0.00625	CcSEcCtD
Vildagliptin—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00385	0.00624	CcSEcCtD
Vildagliptin—Arthralgia—Topotecan—ovarian cancer	0.00384	0.00622	CcSEcCtD
Vildagliptin—Dermatitis bullous—Docetaxel—ovarian cancer	0.00382	0.00619	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00381	0.00617	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00373	0.00605	CcSEcCtD
Vildagliptin—Infection—Topotecan—ovarian cancer	0.00365	0.00592	CcSEcCtD
Vildagliptin—Pancreatitis—Paclitaxel—ovarian cancer	0.00365	0.00591	CcSEcCtD
Vildagliptin—Nervous system disorder—Topotecan—ovarian cancer	0.00361	0.00585	CcSEcCtD
Vildagliptin—Oedema—Melphalan—ovarian cancer	0.0036	0.00584	CcSEcCtD
Vildagliptin—Infection—Melphalan—ovarian cancer	0.00358	0.0058	CcSEcCtD
Vildagliptin—Skin disorder—Topotecan—ovarian cancer	0.00357	0.00579	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00357	0.00578	CcSEcCtD
Vildagliptin—Fatigue—Chlorambucil—ovarian cancer	0.00356	0.00577	CcSEcCtD
Vildagliptin—Hyperhidrosis—Topotecan—ovarian cancer	0.00355	0.00576	CcSEcCtD
Vildagliptin—Angioedema—Vinorelbine—ovarian cancer	0.00352	0.00571	CcSEcCtD
Vildagliptin—Skin disorder—Melphalan—ovarian cancer	0.0035	0.00567	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00346	0.0056	CcSEcCtD
Vildagliptin—Weight increased—Paclitaxel—ovarian cancer	0.00339	0.00549	CcSEcCtD
Vildagliptin—Liver function test abnormal—Docetaxel—ovarian cancer	0.00337	0.00546	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00335	0.00543	CcSEcCtD
Vildagliptin—Infestation NOS—Paclitaxel—ovarian cancer	0.00332	0.00538	CcSEcCtD
Vildagliptin—Infestation—Paclitaxel—ovarian cancer	0.00332	0.00538	CcSEcCtD
Vildagliptin—Urticaria—Chlorambucil—ovarian cancer	0.00328	0.00532	CcSEcCtD
Vildagliptin—Arthralgia—Vinorelbine—ovarian cancer	0.00328	0.00532	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00328	0.00532	CcSEcCtD
Vildagliptin—Nasopharyngitis—Docetaxel—ovarian cancer	0.00326	0.00529	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00326	0.00528	CcSEcCtD
Vildagliptin—Skin exfoliation—Epirubicin—ovarian cancer	0.00324	0.00525	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00317	0.00515	CcSEcCtD
Vildagliptin—Fatigue—Topotecan—ovarian cancer	0.00317	0.00514	CcSEcCtD
Vildagliptin—Constipation—Topotecan—ovarian cancer	0.00314	0.0051	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00314	0.00509	CcSEcCtD
Vildagliptin—Infection—Vinorelbine—ovarian cancer	0.00312	0.00507	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00311	0.00504	CcSEcCtD
Vildagliptin—Fatigue—Melphalan—ovarian cancer	0.0031	0.00503	CcSEcCtD
Vildagliptin—Nervous system disorder—Vinorelbine—ovarian cancer	0.00308	0.005	CcSEcCtD
Vildagliptin—Skin disorder—Vinorelbine—ovarian cancer	0.00305	0.00495	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—ovarian cancer	0.00299	0.00485	CcSEcCtD
Vildagliptin—Asthenia—Chlorambucil—ovarian cancer	0.00296	0.0048	CcSEcCtD
Vildagliptin—Oedema peripheral—Paclitaxel—ovarian cancer	0.00293	0.00476	CcSEcCtD
Vildagliptin—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00293	0.00474	CcSEcCtD
Vildagliptin—Urticaria—Topotecan—ovarian cancer	0.00292	0.00473	CcSEcCtD
Vildagliptin—Weight increased—Docetaxel—ovarian cancer	0.00287	0.00465	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00287	0.00465	CcSEcCtD
Vildagliptin—Urticaria—Melphalan—ovarian cancer	0.00286	0.00464	CcSEcCtD
Vildagliptin—Diarrhoea—Chlorambucil—ovarian cancer	0.00283	0.00458	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00282	0.00456	CcSEcCtD
Vildagliptin—Infestation—Docetaxel—ovarian cancer	0.00281	0.00456	CcSEcCtD
Vildagliptin—Infestation NOS—Docetaxel—ovarian cancer	0.00281	0.00456	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00272	0.0044	CcSEcCtD
Vildagliptin—Fatigue—Vinorelbine—ovarian cancer	0.00271	0.0044	CcSEcCtD
Vildagliptin—Angiopathy—Paclitaxel—ovarian cancer	0.0027	0.00438	CcSEcCtD
Vildagliptin—Constipation—Vinorelbine—ovarian cancer	0.00269	0.00436	CcSEcCtD
Vildagliptin—Chills—Paclitaxel—ovarian cancer	0.00267	0.00433	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00266	0.00431	CcSEcCtD
Vildagliptin—Asthenia—Topotecan—ovarian cancer	0.00264	0.00428	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00261	0.00422	CcSEcCtD
Vildagliptin—Malnutrition—Paclitaxel—ovarian cancer	0.00259	0.0042	CcSEcCtD
Vildagliptin—Asthenia—Melphalan—ovarian cancer	0.00258	0.00419	CcSEcCtD
Vildagliptin—Dermatitis bullous—Epirubicin—ovarian cancer	0.00257	0.00417	CcSEcCtD
Vildagliptin—Flatulence—Paclitaxel—ovarian cancer	0.00255	0.00414	CcSEcCtD
Vildagliptin—Hepatitis—Docetaxel—ovarian cancer	0.00252	0.00409	CcSEcCtD
Vildagliptin—Hypoglycaemia—Epirubicin—ovarian cancer	0.00252	0.00409	CcSEcCtD
Vildagliptin—Diarrhoea—Topotecan—ovarian cancer	0.00252	0.00408	CcSEcCtD
Vildagliptin—Urticaria—Vinorelbine—ovarian cancer	0.0025	0.00405	CcSEcCtD
Vildagliptin—Oedema peripheral—Docetaxel—ovarian cancer	0.00249	0.00403	CcSEcCtD
Vildagliptin—Connective tissue disorder—Docetaxel—ovarian cancer	0.00248	0.00402	CcSEcCtD
Vildagliptin—Diarrhoea—Melphalan—ovarian cancer	0.00246	0.00399	CcSEcCtD
Vildagliptin—Nausea—Chlorambucil—ovarian cancer	0.00245	0.00398	CcSEcCtD
Vildagliptin—Dizziness—Topotecan—ovarian cancer	0.00243	0.00394	CcSEcCtD
Vildagliptin—Tremor—Paclitaxel—ovarian cancer	0.00243	0.00394	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00238	0.00386	CcSEcCtD
Vildagliptin—Angioedema—Paclitaxel—ovarian cancer	0.00237	0.00384	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00233	0.00378	CcSEcCtD
Vildagliptin—Headache—Topotecan—ovarian cancer	0.0023	0.00373	CcSEcCtD
Vildagliptin—Angiopathy—Docetaxel—ovarian cancer	0.00229	0.00371	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—ovarian cancer	0.00227	0.00368	CcSEcCtD
Vildagliptin—Chills—Docetaxel—ovarian cancer	0.00226	0.00367	CcSEcCtD
Vildagliptin—Asthenia—Vinorelbine—ovarian cancer	0.00226	0.00366	CcSEcCtD
Vildagliptin—Arthralgia—Paclitaxel—ovarian cancer	0.00221	0.00358	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—ovarian cancer	0.0022	0.00357	CcSEcCtD
Vildagliptin—Malnutrition—Docetaxel—ovarian cancer	0.0022	0.00356	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00219	0.00355	CcSEcCtD
Vildagliptin—Nausea—Topotecan—ovarian cancer	0.00218	0.00354	CcSEcCtD
Vildagliptin—Diarrhoea—Vinorelbine—ovarian cancer	0.00215	0.00349	CcSEcCtD
Vildagliptin—Nausea—Melphalan—ovarian cancer	0.00214	0.00347	CcSEcCtD
Vildagliptin—Oedema—Paclitaxel—ovarian cancer	0.00212	0.00343	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.0021	0.00341	CcSEcCtD
Vildagliptin—Infection—Paclitaxel—ovarian cancer	0.0021	0.00341	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—ovarian cancer	0.00209	0.00338	CcSEcCtD
Vildagliptin—Dizziness—Vinorelbine—ovarian cancer	0.00208	0.00337	CcSEcCtD
Vildagliptin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00207	0.00336	CcSEcCtD
Vildagliptin—Skin disorder—Paclitaxel—ovarian cancer	0.00205	0.00333	CcSEcCtD
Vildagliptin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00205	0.00332	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00204	0.0033	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00198	0.0032	CcSEcCtD
Vildagliptin—Headache—Vinorelbine—ovarian cancer	0.00197	0.00319	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—ovarian cancer	0.00194	0.00314	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—ovarian cancer	0.00193	0.00313	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00193	0.00312	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—ovarian cancer	0.0019	0.00307	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—ovarian cancer	0.0019	0.00307	CcSEcCtD
Vildagliptin—Arthralgia—Docetaxel—ovarian cancer	0.00187	0.00303	CcSEcCtD
Vildagliptin—Nausea—Vinorelbine—ovarian cancer	0.00187	0.00303	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00186	0.00301	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00183	0.00296	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00183	0.00296	CcSEcCtD
Vildagliptin—Fatigue—Paclitaxel—ovarian cancer	0.00182	0.00296	CcSEcCtD
Vildagliptin—Constipation—Paclitaxel—ovarian cancer	0.00181	0.00293	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00179	0.00291	CcSEcCtD
Vildagliptin—Oedema—Docetaxel—ovarian cancer	0.00179	0.00291	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—ovarian cancer	0.00179	0.0029	CcSEcCtD
Vildagliptin—Infection—Docetaxel—ovarian cancer	0.00178	0.00289	CcSEcCtD
Vildagliptin—Nervous system disorder—Docetaxel—ovarian cancer	0.00176	0.00285	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—ovarian cancer	0.00175	0.00284	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—ovarian cancer	0.00175	0.00284	CcSEcCtD
Vildagliptin—Skin disorder—Docetaxel—ovarian cancer	0.00174	0.00282	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—ovarian cancer	0.0017	0.00276	CcSEcCtD
Vildagliptin—Urticaria—Paclitaxel—ovarian cancer	0.00168	0.00272	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—ovarian cancer	0.00168	0.00272	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—ovarian cancer	0.00167	0.00271	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00166	0.00269	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00163	0.00265	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—ovarian cancer	0.00158	0.00255	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—ovarian cancer	0.00155	0.00252	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00155	0.00251	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00155	0.00251	CcSEcCtD
Vildagliptin—Fatigue—Docetaxel—ovarian cancer	0.00155	0.00251	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—ovarian cancer	0.00154	0.0025	CcSEcCtD
Vildagliptin—Constipation—Docetaxel—ovarian cancer	0.00153	0.00249	CcSEcCtD
Vildagliptin—Chills—Epirubicin—ovarian cancer	0.00153	0.00248	CcSEcCtD
Vildagliptin—Asthenia—Paclitaxel—ovarian cancer	0.00152	0.00246	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—ovarian cancer	0.00148	0.0024	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—ovarian cancer	0.00146	0.00237	CcSEcCtD
Vildagliptin—Diarrhoea—Paclitaxel—ovarian cancer	0.00145	0.00235	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—ovarian cancer	0.00143	0.00232	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—ovarian cancer	0.00141	0.00229	CcSEcCtD
Vildagliptin—Dizziness—Paclitaxel—ovarian cancer	0.0014	0.00227	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—ovarian cancer	0.00137	0.00222	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—ovarian cancer	0.00135	0.00219	CcSEcCtD
Vildagliptin—Headache—Paclitaxel—ovarian cancer	0.00133	0.00215	CcSEcCtD
Vildagliptin—Asthenia—Docetaxel—ovarian cancer	0.00129	0.00209	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—ovarian cancer	0.00126	0.00205	CcSEcCtD
Vildagliptin—Nausea—Paclitaxel—ovarian cancer	0.00126	0.00204	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00125	0.00203	CcSEcCtD
Vildagliptin—Diarrhoea—Docetaxel—ovarian cancer	0.00123	0.00199	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—ovarian cancer	0.00121	0.00196	CcSEcCtD
Vildagliptin—Infection—Epirubicin—ovarian cancer	0.0012	0.00195	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—ovarian cancer	0.00119	0.00192	CcSEcCtD
Vildagliptin—Dizziness—Docetaxel—ovarian cancer	0.00119	0.00192	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—ovarian cancer	0.00117	0.0019	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—ovarian cancer	0.00117	0.0019	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—ovarian cancer	0.00117	0.00189	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00116	0.00188	CcSEcCtD
Vildagliptin—Headache—Docetaxel—ovarian cancer	0.00112	0.00182	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—ovarian cancer	0.00112	0.00181	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—ovarian cancer	0.00111	0.0018	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.0011	0.00179	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—ovarian cancer	0.0011	0.00178	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—ovarian cancer	0.00109	0.00176	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00108	0.00175	CcSEcCtD
Vildagliptin—Nausea—Docetaxel—ovarian cancer	0.00107	0.00173	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00104	0.00169	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—ovarian cancer	0.00104	0.00169	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—ovarian cancer	0.00103	0.00168	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00102	0.00165	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000966	0.00157	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—ovarian cancer	0.000965	0.00156	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—ovarian cancer	0.000961	0.00156	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—ovarian cancer	0.000957	0.00155	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—ovarian cancer	0.000889	0.00144	CcSEcCtD
Vildagliptin—Asthenia—Epirubicin—ovarian cancer	0.000868	0.00141	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—ovarian cancer	0.000827	0.00134	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—ovarian cancer	0.000803	0.0013	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—ovarian cancer	0.0008	0.0013	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—ovarian cancer	0.000766	0.00124	CcSEcCtD
Vildagliptin—Headache—Epirubicin—ovarian cancer	0.000758	0.00123	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—ovarian cancer	0.00074	0.0012	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—ovarian cancer	0.000718	0.00116	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—ovarian cancer	0.000701	0.00114	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—ovarian cancer	0.000665	0.00108	CcSEcCtD
